Updated:
TELUS
Darren Entwistle's TELUS runs a C$60B market-cap telecom that doubles as one of Canada's largest healthcare IT investors through its Telus Ventures arm.
TELUS
TELUS launched in 1990 as a government-owned Alberta telephone provider before privatizing and expanding nationally under Darren Entwistle, who became CEO in 2000. The firm's wealth engine derives from its position as one of Canada's three national wireless carriers, generating free cash flow that fuels an aggressive diversification strategy. Telus International, a digital customer-experience subsidiary carved out and taken public in 2021, now operates in over 30 countries. Telus Ventures, the strategic investment arm, deploys capital across three primary asset classes: growth-stage venture equity, corporate venture co-investments, and asset-backed infrastructure. Its venture mandate targets digital-health platforms, agricultural technology firms, and enterprise-software companies that leverage TELUS connectivity infrastructure. Confirmed portfolio positions include Babylon Health, a digital-first primary-care provider that integrated with Telus Health virtual care services, and Aura Health, a workplace wellbeing platform acquired by Telus in 2021. The partnership with Babylon Health, announced during the COVID-19 acceleration of telehealth, exemplifies the fund's doctrine of embedding its consumption economy within its own capitalized network. Geographically, Telus Ventures concentrates on North America, with select deals in the UK and Israel markets. TELUS reported total assets of C$57 billion on its 2024 year-end financial statements, with Telus Health contributing C$2.1 billion in annual revenue and Telus Agriculture & Consumer Goods reaching C$1.1 billion. The firm operates innovation hubs in Vancouver, Toronto, and Calgary, each anchored to a Telus Health or Telus Ag facility. September 2024: Telus closed the sale of a significant minority stake in its digital-health division to private investors at a valuation that implied the unit was worth roughly C$15 billion, according to the company's quarterly filing. TELUS's structural differentiator lies in its corporate venture capital model, which deploys patient balance-sheet capital with an explicit commercial-synergy mandate. Unlike standalone venture funds that must return capital to limited partners, Telus Ventures can hold positions indefinitely, acting as both a strategic partner and a distribution channel for portfolio companies integrated into Telus Health or Telus Agriculture platforms. This embedded-capital approach effectively converts connectivity infrastructure into a distribution moat for its venture bets.
General information
Firm type
Asset Manager
Year founded
1990
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Vancouver
Corporate office
Vancouver, BC, Canada
Additional offices
Toronto, Canada · Calgary, Canada · Montreal, Canada
Principals
Darren Entwistle
President & CEO
Sector focus
Frequently asked questions
How does TELUS source its venture deals?
Telus Ventures sources through a combination of direct outreach by its in-house investment team, partnerships with Canadian and Israeli accelerators, and inbound referrals from the Telus Health and Telus Agriculture business units. The firm's corporate development team fields roughly 500 pitches annually, according to a 2023 corporate presentation, with an emphasis on startups that can pilot within Telus's existing customer base in healthcare, agriculture, or field-service management.
What is Telus Health, and how does it relate to the venture program?
Telus Health is a wholly owned division that combines acquired healthcare IT companies, virtual care platforms, and electronic medical record systems serving over 70 million patients globally. It functions as both a business unit and a primary deployment channel for Telus Ventures portfolio companies, which can integrate their software directly into Telus Health's physician-facing or patient-facing platforms. The division accounted for roughly 11% of TELUS total revenue as of year-end 2024.
Does TELUS participate in fund commitments or only direct deals?
TELUS primarily executes direct equity investments and corporate venture co-investments. The firm has occasionally participated as a limited partner in specialized ag-tech funds, including Finistere Ventures, where it acted as an anchor LP in the firm's Canada-focused agri-food technology vehicle. The majority of its deployment, however, is balance-sheet direct investing.
Who runs investment decisions at Telus Ventures?
Investment decisions at Telus Ventures are led by the Managing Partner of Telus Ventures, a role historically held by Rich Osborn, who has directed venture strategy since the unit's 2001 founding. The investment committee includes the TELUS Chief Strategy Officer and senior leaders from Telus Health and Telus Agriculture, ensuring commercial alignment with the parent company's operating divisions.
Which sectors does TELUS explicitly avoid?
Telus Ventures does not invest in consumer social media, gaming, or advertising-technology platforms, and its mandate explicitly excludes hardware-dependent deep-tech ventures that lack a clear software-as-a-service distribution model. The firm also avoids pure-play fintech unless the application directly serves healthcare payments or agricultural supply-chain finance.
How is Telus Ventures structurally separated from the public telecom entity?
Telus Ventures is not a separate legal entity but rather a division within TELUS Corporation that draws its capital from the corporate treasury. It reports through the Chief Strategy Officer rather than through the CFO or a traditional limited-partner structure. This means its portfolio valuations are consolidated into TELUS's public financials but not broken out as a separate segment.
What is TELUS's known posture on co-investments alongside external GPs?
TELUS welcomes co-investors alongside its venture bets, particularly growth-stage rounds where it acts as a strategic rather than lead investor. The firm has co-invested alongside institutional venture firms including Andreessen Horowitz and Georgian Partners, according to pitchbook records, and frequently participates in syndicates led by Canadian venture funds with overlapping healthcare or agriculture mandates.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: